The Gene of the Ubiquitin-Specific Protease 8 Is Frequently Mutated in Adenomas Causing Cushing's Disease
Context: We have recently reported somatic mutations in the ubiquitin-specific protease USP8 gene in a small series of adenomas of patients with Cushing's disease. Objective: To determine the prevalence of USP8 mutations and the genotype-phenotype correlation in a large series of patients diagn...
Saved in:
Published in: | The journal of clinical endocrinology and metabolism Vol. 100; no. 7; pp. E997 - E1004 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
Endocrine Society
01-07-2015
Copyright by The Endocrine Society |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Context:
We have recently reported somatic mutations in the ubiquitin-specific protease USP8 gene in a small series of adenomas of patients with Cushing's disease.
Objective:
To determine the prevalence of USP8 mutations and the genotype-phenotype correlation in a large series of patients diagnosed with Cushing's disease.
Design:
We performed a retrospective, multicentric, genetic analysis of 134 functioning and 11 silent corticotroph adenomas using Sanger sequencing. Biochemical and clinical features were collected and examined within the context of the mutational status of USP8, and new mutations were characterized by functional studies.
Patients:
A total of 145 patients who underwent surgery for an ACTH-producing pituitary adenoma.
Main Outcomes Measures:
Mutational status of USP8. Biochemical and clinical features included sex, age at diagnosis, tumor size, preoperative and postoperative hormonal levels, and comorbidities.
Results:
We found somatic mutations in USP8 in 48 (36%) pituitary adenomas from patients with Cushing's disease but in none of 11 silent corticotropinomas. The prevalence was higher in adults than in pediatric cases (41 vs 17%) and in females than in males (43 vs 17%). Adults having USP8-mutated adenomas were diagnosed at an earlier age than those with wild-type lesions (36 vs 44 y). Mutations were primarily found in adenomas of 10 ± 7 mm and were inversely associated with the development of postoperative adrenal insufficiency. All the mutations affected the residues Ser718 or Pro720, including five new identified alterations. Mutations reduced the interaction between USP8 and 14-3-3 and enhanced USP8 activity. USP8 mutants diminished epidermal growth factor receptor ubiquitination and induced Pomc promoter activity in immortalized AtT-20 corticotropinoma cells.
Conclusions:
USP8 is frequently mutated in adenomas causing Cushing's disease, especially in those from female adult patients diagnosed at a younger age. |
---|---|
Bibliography: | The study was supported by the Else Kröner-Fresenius-Stiftung (Grant 2012_A103; to M.R.) and Grants-in-aid from the Ministry of Education, Culture, Science and Technology of Japan (Grant 24112003; to M.Kom.). L.G.P.-R. is supported by a grant from the German Research Foundation (Grant RE 752/20-1). M.The. is supported by a grant from the German Federal Ministry of Education and Research (01EX1021B, Spitzencluster M4, Verbund Personalisierte Medizin, Teilprojekt NeoExNET [PM1]). The research leading to these results has received funding from the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7/2007–2013) under REA grant agreement no. 608765 and was also, in part, supported by the intramural research program of the National Institute of Child Health and Human Development, National Institutes of Health (to C.A.S.) and by a research grant by Pfizer (to M.Kor.). L.G.P.-R. and M.R. had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. The funder institutions had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or the decision to submit the manuscript for publication. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 L.G.P.-R., M.The., M.Kor., M.Kom., and M.R. contributed equally to this work. |
ISSN: | 0021-972X 1945-7197 |
DOI: | 10.1210/jc.2015-1453 |